Everything below concerns prothymosin alpha. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
In lichenology, simple chemical spot tests are used to detect certain compounds in situ, and X. parietina yields clear results due to its anthraquinone pigments. A standard test is the K test (using potassium hydroxide solution). On X. parietina, applying KOH to the cortex produces a deep purple reaction (K+ purple). This is a classic indication of anthraquinones like parietin – the KOH causes parietin to form a purple salt (a distinctive color change). Other spot test results for this lichen are negative: C−, KC−, and P−. In addition to its anthraquinone pigments, Xanthoria parietina contains small amounts of calcium oxalate, a secondary metabolite that occurs in many lichens, particularly those growing on calcareous substrates. However, unlike strictly calcicolous species such as Caloplaca heppiana and Lecanora calcarea, which accumulate large quantities of calcium oxalate, X. parietina was found to contain only minor traces of this compound. This suggests that while X. parietina can tolerate limestone habitats, it does not rely on extensive oxalate production for calcium regulation or substrate modification to the same extent as obligate calcicoles.
https://doi.org/10.1016/j.jmb.2007.11.082 Switching DNA-binding specificity by unnatural amino acid substitution. Maiti, A., & Roy, S.* (2005) Nucleic Acids Res, 33, 5896-903. https://doi.org/10.1093/nar/gki899 Asynchronous basepair openings in transcription initiation: regulation by enhancing the rate limiting step. Roy, S., Lim, HM., & Adhya, S. (2004) EMBO J, 23, 869-75. https://doi.org/10.1038/sj.emboj.7600098 Fluorescence quenching methods to study protein-nucleic acid interaction. Roy, S.* (2004) Methods Enzymol, 379, 175-87. https://doi.org/10.1016/S0076-6879(04)79010-2 2-Aminopurine as a probe for Basepair opening during Transcription Initiation. Roy, S.* (2003) Methods Enzymol, 370, 568-76. https://doi.org/10.1016/S0076-6879(03)70048-2 Glutamate counteracts the denaturing effect of urea through its effect on the denatured state. Mandal, AK., Samaddar, S., Banerjee, R., Lahiri, S., Bhattacharyya, A., & Roy, S.* (2003) J Biol Chem, 278, 36077-84. https://doi.org/10.1074/jbc.M211207200 Solvation Change and Ion release During Aminoacylation by Aminoacyl-tRNA synthetases. Bannerjee, R., Mandal, AK., Shah, R., Guha, S., Samaddar, S., Bhattacharyya, A., & Roy, S.* (2003) Nucleic Acids Res, 31, 6035-42. https://doi.org/10.1093/nar/gkg779 Aib-based peptide backbone as scaffolds for helical peptide mimics. Banerjee, R., Basu, G.,* Roy, S.,* & Chene, P. (2002) J Pept Res, 60, 88-94.https://doi.org/10.1034/j.1399-3011.2002.201005.x DnaK-sigma32 interaction is temperature dependent: Implication for the mechanism of heat-shock response.
=== Post-World War II === Bektashism continued to flourish until the Second World War. After the communists took power in 1945, several babas and dervishes were executed and a gradual constriction of Bektashi influence began. Ultimately, in 1967 all tekkes were shut down when Enver Hoxha banned all religious practice. When the ban was rescinded in 1990, the Bektashism reestablished itself, although there were few left with any real knowledge of the spiritual path. Nevertheless, many tekkes (lodges) operate today in Albania. The most recent head of the order in Albania was Hajji Dedebaba Reshat Bardhi (1935–2011) and the main tekke has been reopened in Tirana. In June 2011, Baba Edmond Brahimaj was chosen as the head of the Bektashi Order by a council of Albanian babas. Today, sympathy for the Order is generally widespread in Albania where approximately 20% to 25% of Muslims self-report as having some connection to Bektashism. Despite the negative effect of Turkey's ban on lodges on Bektashi life, most contemporary Turkish Bektashis have been generally supportive of the country's Kemalist secularism, since Ataturk's reforms have lessened the religious intolerance historically demonstrated towards the community by the Sunni religious establishment during Ottoman times.
1956: The association "La Maternité Heureuse," which would become the French Movement for Family Planning (MFPF) in 1960, is founded; its goals include sex education and advocacy for the right to contraception and abortion. December 11, 1956: Law on the housewife allowance, extended beyond agricultural professions. March 25, 1957: Treaty of Rome establishing the European Economic Community; it includes a principle of equal pay for men and women for identical work.
=== Probing pocket depth (PPD) === Pocket depth is the distance from the gingival margin to the base of the pocket. The position of the gingival margin can change due to swelling or recession, and vary with inflammation if force of probing, therefore, probing depth measurement alone is not recommended for assessment of changes in periodontal support over time.
Sources: en.wikipedia.org
Serum albumins are the most common plasma proteins, and they are responsible for maintaining the osmotic pressure of the blood. Without albumins, the consistency of blood would be closer to that of water. The increased viscosity of blood prevents fluid from entering the bloodstream from outside the capillaries. Albumins are produced in the liver, assuming the absence of a hepatocellular deficiency.
== Sites of synthesis == Leptin is produced primarily in the adipocytes of white adipose tissue. It also is produced by brown adipose tissue, placenta (syncytiotrophoblasts), ovaries, skeletal muscle, stomach (the lower part of the fundic glands), mammary epithelial cells, bone marrow, gastric chief cells, and P/D1 cells.
Jan Jozef van Deemter (31 March 1918 – 10 October 2004) was a Dutch physicist and engineer known for the Van Deemter equation in chromatography. He obtained his doctorate in physics from the University of Amsterdam in June of 1950. Starting in 1947 he began work for Royal Dutch Shell as a researcher and it was there that he developed and published his article in 1956.
Following the London Declaration of 1949, where it was agreed that India could be a full member of the Commonwealth as a republic, not a dominion, the leaders of the Commonwealth countries agreed that the other members of the Commonwealth should not continue to be referred to as dominions. In 1951, Prime Minister Louis St. Laurent announced in the Canadian House of Commons that in light of the Statute of Westminster, 1931, and the changes to the Commonwealth, dominion was no longer an accurate term to use to refer to Canada and would no longer be used by the federal government. Similarly by 1952, the United Kingdom no longer used the term dominions to refer to Canada or other members of the Commonwealth, instead beginning to use the term a realm of the Commonwealth. The Canada Act 1982, which brought the Constitution of Canada fully under Canadian control, referred only to Canada. Later that year, the name of the national holiday was changed from Dominion Day to Canada Day.
Sources: en.wikipedia.org
== Enzyme regulation == NADP-ME expression has been shown to be regulated by abiotic stress factors. For CAM plants, drought conditions cause stoma to largely remain shut to avoid water loss by evapotranspiration, which leads to CO2 starvation. In compensation, closed stoma activates the translation of NADP-ME to reinforce high efficiency of CO2 assimilation during the brief intervals of CO2 intake, allowing for carbon fixation to continue. In addition to regulation at the longer time scale by means of expression control, regulation at the short-time scale can occur through allosteric mechanisms. C4 NADP-ME has been shown to be partially inhibited by its substrate, malate, suggesting two independent binding sites: one at the active site and one at an allosteric site. However, the inhibitory effect exhibits pH-dependence – existent at a pH of 7 but not a pH of 8. The control of enzyme activity due to pH changes align with the hypothesis that NADP-ME is most active while photosynthesis is in progress: Active light reactions leads to a rise in basicity within the chloroplast stroma, the location of NADP-ME, leading to a diminished inhibitory effect of malate on NADP-ME and thereby promoting a more active state. Conversely, slowed light reactions leads to a rise in acidity within the stroma, promoting the inhibition of NADP-ME by malate. Because the high energy products of the light reactions, NADPH and ATP, are required for the Calvin cycle to proceed, a buildup of CO2 without them is not useful, explaining the need for the regulatory mechanism.
== History == As a by-product of his work on type-specific staphylococcus antigens, Verwey reported in 1940 that a protein fraction prepared from extracts of these bacteria non-specifically precipitated rabbit antisera raised against different staphylococcus types. In 1958, Jensen confirmed Verwey's finding and showed that rabbit pre-immunization sera as well as normal human sera bound to the active component in the staphylococcus extract; he designated this component Antigen A (because it was found in fraction A of the extract) but thought it was a polysaccharide. The misclassification of the protein was the result of faulty tests, but it was not long thereafter (1962) that Löfkvist and Sjöquist corrected the error and confirmed that Antigen A was in fact a surface protein on the bacterial wall of certain strains of S. aureus. The Bergen group from Norway named the protein "Protein A" after the antigen fraction isolated by Jensen.
== Research == A 2016 review found that reserpine reduced systolic blood pressure (SBP) by about 8 mmHg compared to placebo, and may be as effective at reducing SBP as other front-line hypertensive drugs, although more research is needed to determine a dose-specific safety profile.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.